Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 59, p. e21414, 2023. DOI: 10.1590/s2175-97902023e21414. Disponível em: https://www.revistas.usp.br/bjps/article/view/211884.. Acesso em: 2 may. 2024.